All News
Tony Bennett’s Alzheimer’s Diagnosis Again Puts Spotlight on Link Between Music, Memory
GAP-Net site, the University of California Irvine’s UCIMind is quoted about how music may play a role in preserving memory and delaying Alzheimer’s disease. IRVINE (CBSLA) — On Monday, it was revealed that legendary singer Tony Bennett has been battling Alzheimer’s disease for more than four years. On Monday, it was revealed that singer Tony Bennett, seen here […]
National Institutes of Health Awards Cleveland Clinic $6.7 Million Grant to Evaluate Impact of High-Intensity Exercise in Preventing Alzheimer’s Disease
GAP-Net site Cleveland Clinic was awarded a grant by the NIH to evaluate if high-intensity exercise can prevent development of Alzheimer’s disease. The National Institutes of Health has awarded Cleveland Clinic a $6.7 million grant to evaluate if high-intensity exercise can prevent development of Alzheimer’s disease. The five-year study will assess the effect of home-based indoor cycling […]
STATEMENT: ELI LILLY’S PHASE 2 DONANEMAB STUDY RESULT IS CAUSE FOR CELEBRATION
Statement by GAP President John Dwyer on the results of the Phase 2 trial for Donanemab: We congratulate Eli Lilly on the results of the Donanemab clinical trial showing it significantly slowed the cognitive and functional decline of people with mild Alzheimer’s. This is a major step towards discovery of a disease modifying therapy. Alzheimer’s […]
STATEMENT: BIOGEN AND APPLE PARTNERSHIP SPEEDS SEARCH FOR ALZHEIMER’S TEST; SHOULD PRIORITIZE DIVERSITY
Statement by Global Alzheimer’s Platform Foundation (GAP) President John Dwyer on today’s announcement that Biogen and Apple are partnering on an observational study to investigate the role Apple Watch and iPhone could play in screening for mild cognitive impairment (MCI): Today’s announcement by Biogen and Apple marks a significant step on the path to early […]
Aducanumab for Alzheimer’s: One Drug, Two Results
A clinical trial participant from #GAPNet site, JEM Research, talks with her husband about their experience in the Aducanumab trial, which is pending approval by the US Food and Drug Administration by March 2021. There are currently more than five million Americans living with Alzheimer’s disease… and despite ongoing research, there has been no new […]
Chris Sprowls Reaches Across the Aisle to Name Matt Willhite to Alzheimer’s Disease Advisory Committee
GAP 2020 Citizen Scientist Collaborator Award National Honoree, Rep. Matt Willhite was named to the Florida House Alzheimer’s Disease Advisory Committee. This week, state House Speaker Chris Sprowls, R-Palm Harbor, reached across the aisle to name state Rep. Matt Willhite, D-Wellington, to the Alzheimer’s Disease Advisory Committee. The Alzheimer’s Disease Advisory Committee has 15 members and meets every quarter […]
Alzheimer’s Disease: An Epidemic in Rural America
GAP CSO, Dr. Richard Mohs, testified in front of US Senators about Alzheimer’s disease. He was quoted by RFD TV about how it affects rural America. While many of us are focused on the pandemic, chances are you know someone who is battling Alzheimer’s disease. Healthcare experts call it an epidemic in rural America. Lawmakers […]
Investment in Diversity and Rapid, Early Diagnostics Is Essential to the Search for a Cure for Alzheimer’s Disease
Global Alzheimer’s Platform Foundation® Chief Science Officer Dr. Richard Mohs testifies at Senate hearing about the Alzheimer’s crisis. Watch the full hearing at United States Senate Committee on Finance. Washington, DC (December 16, 2020) – Today, the Chief Science Officer of the Global Alzheimer’s Platform Foundation® (GAP), Dr. Richard Mohs, testified before the Senate Committee on Finance, […]
Running Clinical Trials in a Pandemic
GAP-Net site Stanford Neurology and Neurosurgery Clinical Trials at Stanford University talked about how researchers have gotten creative when it comes to continuing clinical trials during the COVID-19 Pandemic. At the beginning of the coronavirus pandemic, clinical trials came to a screeching halt. But as researchers and doctors have gained a better understanding of SARS-CoV-2, […]
Clinical Trial for Alzheimer’s Drug, Aducanumab Shows Promise
Citizen Scientist Mike O’Brien from GAP-Net site JEM Research is participating in the Biogen clinical trial for Aducanumab, which is under consideration by the US Food and Drug Administration (FDA). Sue and Mike O’Brien moved to South Florida about six years ago. One of her favorite sayings back then was ‘Really’? One night she realized […]